EVEROLIMUS
everolimus 2 mg dispersible tablet, 30
EVEROLIMUS (11591C)
11591C
Manner of administration:Oral
Restriction
Indication: Refractory seizures associated with tuberous sclerosis complex
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: $368.48 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Afinitor | |||||